Free Trial

Members Wealth LLC Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Members Wealth LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,271 shares of the healthcare conglomerate's stock, valued at approximately $1,198,000. UnitedHealth Group accounts for about 0.9% of Members Wealth LLC's investment portfolio, making the stock its 29th biggest holding.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Capital & Planning LLC lifted its position in shares of UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after purchasing an additional 79 shares during the last quarter. Brighton Jones LLC raised its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in UnitedHealth Group by 2.0% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 6,916 shares of the healthcare conglomerate's stock valued at $3,498,000 after purchasing an additional 133 shares during the last quarter. Union Bancaire Privee UBP SA bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $27,233,000. Finally, Pacer Advisors Inc. grew its position in shares of UnitedHealth Group by 6.2% during the 4th quarter. Pacer Advisors Inc. now owns 73,275 shares of the healthcare conglomerate's stock valued at $37,067,000 after buying an additional 4,295 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Wolfe Research dropped their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a report on Thursday, May 15th. HSBC reaffirmed a "reduce" rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Finally, Barclays lowered their target price on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $441.87.

View Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $2.91 during trading hours on Friday, reaching $301.08. 16,264,467 shares of the company were exchanged, compared to its average volume of 10,719,536. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market cap of $273.12 billion, a price-to-earnings ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average of $435.12 and a 200 day moving average of $496.39.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the business earned $6.91 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Transactions at UnitedHealth Group

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 over the last three months. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines